Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples